Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study

NCT01174810 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University College, London